Immuneering (IMRX) EBITDA Margin (2020 - 2022)
Immuneering (IMRX) recorded quarterly EBITDA Margin of 2886419.34% in Q4 2022, down 8551.21% quarter-over-quarter from 33364.36% in Q3 2022, and down 288070777.0% on a YoY basis from N/an in Q4 2021.
Immuneering (IMRX) EBITDA Margin (2020 - 2022) Analysis & Trends
Immuneering's EBITDA Margin history runs 3 years deep, the most recent figure standing at 2886419.34% for Q4 2022.
- In Q4 2022, EBITDA Margin fell 288070777.0% year-over-year to 2886419.34%; the TTM figure through Sep 2023 stood at 11315518.9% (down 1130599682.0% YoY), while the FY2022 annual figure was 15931.33%, down 1431665.0% from the prior year.
- EBITDA Margin was 2886419.34% for Q4 2022 at Immuneering, down from 33364.36% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 644.49% in Q3 2020 to a low of 2886419.34% in Q4 2022.
- Historically, EBITDA Margin has averaged 268262.7% across 3 years, with a median of 1771.06% in 2021.
- The sharpest annual moves came in 2021 and 2022: EBITDA Margin sank 46010 bps in 2021, then slumped 288070777 bps in 2022.
- A 3-year view of EBITDA Margin shows it stood at 877.48% in 2020, then sank by 551 bps to 5711.57% in 2021, then sank by 50436 bps to 2886419.34% in 2022.
- The last three EBITDA Margin figures came in at 2886419.34% (Q4 2022), 33364.36% (Q3 2022), and 12223.67% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2,886,419.34% |
| Sep 30, 2022 | -33,364.36% |
| Jun 30, 2022 | -12,223.67% |
| Mar 31, 2022 | -7,084.87% |
| Dec 31, 2021 | -5,711.57% |
| Sep 30, 2021 | -1,771.06% |
| Jun 30, 2021 | -1,210.18% |
| Mar 31, 2021 | -832.62% |
| Dec 31, 2020 | -877.48% |
| Sep 30, 2020 | -644.49% |
| Jun 30, 2020 | -750.08% |